1. Home
  2. Analysis
  3. Antivert
  4. Prohance

Antivert and Prohance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antivert (meclizine hydrochloride) and Prohance (gadoteridol). Common drug interactions include nephrogenic systemic fibrosis among females and anaphylactic reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Antivert and Prohance. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Prohance?

Prohance has active ingredients of gadoteridol. eHealthMe is studying from 3,734 Prohance users. Check the latest studies of Prohance.

On Jul, 13, 2026

15 people who take Antivert and Prohance together, and have interactions are studied.

Antivert and Prohance drug interactions.

What are the common drug interactions of Antivert and Prohance, by gender? *:

female:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Skin lesion
  3. Skin tightness
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Deformity (disfigurement)
  7. Dry skin
  8. Emotional distress
  9. Erythema (redness of the skin)
  10. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)

male:

  1. Anaphylactic reaction (serious allergic reaction)

What are the common drug interactions of Antivert and Prohance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Dry skin
  3. Emotional distress
  4. Erythema (redness of the skin)
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. General physical health deterioration (weak health status)
  7. Injury
  8. Joint range of motion decreased (disease of joint movement)
  9. Mobility decreased (ability to move is reduced)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

50-59:

  1. Pain in extremity
  2. Peau d'orange (orange peel skin)
  3. Pruritus (severe itching of the skin)
  4. Scar
  5. Skin atrophy (wasting of skin)
  6. Skin discolouration (change of skin colour)
  7. Skin disorder (skin disease)
  8. Skin hyperpigmentation (disorders affect the colour of your skin)
  9. Skin hypertrophy (skin cells enlarges)
  10. Skin hypopigmentation (loss of skin colour)

60+:

  1. Oxygen saturation decreased
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Sedation

What are the existing conditions these people have? *

  1. Pain: 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and Prohance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Antivert and Prohance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prohance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prohance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride and gadoteridol (the active ingredients of Antivert and Prohance, respectively), and Antivert and Prohance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.